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INTRODUCTION
Pancreatic cancer is projected to move from the third to second leading cause of cancer mortality before 2020 [1] . In contrast to the steady survival increase for most other cancers, advances in management for pancreatic cancer have been less than modest with the 5-year relative survival rate is currently 8% [1] . The primary reason for the low survival is difficulty in early identification of pancreatic cancer. While pancreatic cystic lesions (PCLs) provide an opportunity for early cancer detection as many have malignant potential. There has been a surge in incidental detection of PCLs due to increasing utilization of cross-sectional imaging, but diagnostic differentiation of these lesions remains challenging [2, 3] . Despite judicious utilization of endoscopic ultrasound (EUS), fine needle aspiration (FNA), cyst fluid analysis, and cytology, it is challenging to accurately classify PCLs into non-mucinous [serous cystadenomas (SCA), pseudocysts], pre-malignant mucinous [intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasms (MCN)], and neoplastic [cystic-neuroendocrine tumors (NET), pseudopapillary tumor] PCLs. This is highlighted by a recent study at a large tertiary center involving 851 resected cystic tumors where the associated etiology for one in five cases was benign in nature [4] . Confocal laser endomicroscopy (CLE) offers realtime microscopic imaging of tissue where the system provides tissue-sequences with high resolution (1-3.5 μm) facilitating in vivo histopathology. Needle-based CLE (nCLE) is a new technology to evaluate PCLs where the device is pre-loaded in a 19-guage FNA needle for evaluation of the intracystic epithelium. Recent 
METHODS
In a prospective study evaluating EUS-nCLE for evaluation of PCLs, 10 subjects underwent an in vivo nCLE (AQFlex nCLE miniprobe; Cellvizio, MaunaKea, Paris, France) during EUS and ex vivo probe based CLE (pCLE) of the PCL (Gastroflex ultrahigh definition probe, Cellvizio) after surgical resection. Biopsies were obtained from ex vivo CLE-imaged areas for comparative histopathology. All subjects received intravenous fluorescein prior to EUS and pancreatic surgery for in vivo and ex vivo CLE imaging respectively.
RESULTS
A total of 10 subjects (mean age 53 ± 12 years; 5 female) with a mean PCL size of 34.8 ± 14.3 mm were enrolled. Surgical histopathology confirmed 2 intraductal papillary mucinous neoplasms (IPMNs), 3 mucinous cystic neoplasms (MCNs), 2 cystic neuroendocrine tumors (cystic-NETs), 1 serous cystadenoma (SCA), and 2 squamous lined PCLs. Characteristic in vivo nCLE image patterns included papillary projections for IPMNs, horizon-type epithelial bands for MCNs, nests and trabeculae of cells for cystic-NETs, and a "fern pattern" of vascularity for SCA. Identical image patterns were observed during ex vivo pCLE imaging of the surgically resected PCLs. Both in vivo and ex vivo CLE imaging findings correlated with surgical histopathology.
CONCLUSION
In vivo nCLE patterns are reproducible in ex vivo pCLE for all major neoplastic PCLs. These findings add further support the application of EUS-nCLE as an imaging biomarker in the diagnosis of PCLs.
major trials have established reference standards and have all assessed the safety profile and feasibility of diagnostic capabilities of EUS-guided nCLE in patients with PCLs [5] [6] [7] [8] . More over in vivo nCLE image patterns for PCLs have been internally and externally validated among independent observers [7] [8] [9] [10] .
While ex vivo confirmation of in vivo CLE findings has been demonstrated in diagnosis of Barrett's esophagus and gastric adenocarcinoma, there are no human studies corroborating CLE findings of PCLs using ex-vivo examination and surgical histopathology [11] [12] [13] . We have previously published the technique and individual case reports of IPMN, MCN, SCA, and cystic-NET demonstrating potential feasibility for correlation between in vivo and ex vivo nCLE imaging with surgical histopathology [14] [15] [16] [17] [18] [19] [20] . The aim of this study was to validate the in vivo EUS-nCLE image patterns of specific types of PCLs by reproducing identical images in ex vivo pCLE examination and correlation with surgical histopathology.
MATERIALS AND METHODS

Patient population
The Institutional Review Board approved this prospective study, which was conducted at The Ohio State University Wexner Medical Center. From June 2015 to December 2016, all consenting subjects who underwent EUS-nCLE with subsequent surgical resection were enrolled in the INDEX study (Comparison of confocal laser endomicroscopic in vivo Diagnosis and ex vivo examination against surgical histopathology of cystic pancreatic lesions; ClinicalTrials.gov NCT02516488). An informed consent was obtained for both aspects (in vivo and ex vivo) aspects of the study. Our criteria for using EUS-nCLE included: (1) ≥ 18 years of age; (2) a PCL lesion size of ≥ 20 mm (determined by cross-sectional imaging studies); and (3) evaluation for surgical removal based on recommended international consensus guidelines [21] . Exclusion criteria were: (1) women with known pregnancy at the time of procedure; (2) coagulopathy (INR > 1.5 and/or platelets < 50000/mL); and (3) known allergy to fluorescein. Ex vivo pCLE of PCLs was performed on representative cases of common types of PCLs.
Data collection
Demographics, history of present illness, laboratory data, and image findings were collected using a standardized data collection form. Imaging data were compiled with those from EUS to describe: location, number and size of the PCLs, lesion characteristics, evidence of dilation of the main pancreatic duct, and presence of communication with the pancreatic duct. One gastrointestinal pathologist reviewed all surgical histopathology specimens and the biopsies obtained during ex vivo CLE examination.
In vivo EUS-nCLE image acquisition
All EUS examinations were performed at The Ohio State University Medical Center using a linear echoendoscope (Olympus America, Center Valley, PA, United States). All EUS examinations were performed under the direction of an anesthesiologist utilizing intravenous (IV) propofol. Fluorescein (5 mL; 10% fluorescein sodium) was intravenously injected 2 to 3 min prior to CLE imaging. The AQ-Flex nCLE miniprobe (Cellvizio, Mauna Kea Technologies, Paris, France) was then advanced through the locking device into the 19-gauge (g) needle (Flex needle, Boston Scientific, Natick, MA, United States). The preloaded 19-g needle was advanced under EUS-guidance into the PCL. The tip of the nCLE probe was negotiated until it opposed the intracystic epithelium. Intracystic endomicroscopic images (video) were captured with permissible angulation of the 19 g needle using the elevator of the echoendoscope. After image acquisition, the nCLE probe was withdrawn and the PCL was aspirated. Antibiotic (quinolone) prophylaxis was administered via IV route on the day of procedure followed by 3 d of oral therapy.
Ex vivo pCLE image acquisition
We have recently published a video manual of the ex vivo pCLE imaging technique [19] . Immediately prior to resection of the part of the pancreas with the cystic lesion and under the direction of the surgeon and anesthetist, fluorescein (10%, 5 mL) was intravenously injected before ligation of blood vessels supplying the pancreas. Following resection, the specimen was transported to the pathology-processing laboratory for immediate processing as the pre-ligation IV fluorescein is retained for a maximum of one hour after injection. The pathologist then incised the cyst along the long axis using their standard processing technique. The epithelium of the PCL was then imaged using a Gastroflex ultrahigh definition probe (UHD) probe (Cellvizio, Mauna Kea Technologies, Paris, France) at 3-5 random areas based on the size of the cyst. Site-specific biopsies were then obtained at the pCLE-imaged areas using standard endoscopy biopsy forceps (Radial Jaw 4, Boston Scientific, Natick, MA, United States). The ex vivo biopsies were obtained from the PCL sites providing the clearest pCLE image.
Comparison of the CLE probes
The specific characteristics of the CLE probes used for the study are described in Table 1 . The AQ-Flex nCLE probe was used during in vivo EUS-guided approach while the Gastroflex-UHD pCLE probe with high-definition image acquisition was used during ex vivo post-surgical cyst interrogation. The larger GastroFlex-UHD miniprobe has increased number of fiber optics and provides higher magnification and improved resolution; however, due to its size, the probe cannot be accommodated through the or surgical resection and histopathology reveals a "transverse view", but offers a much higher resolution than CLE imaging, which increases with magnification (Table 1) .
RESULTS
Study cohort
A total of 10 subjects (mean age 53 ± 12 years [SD]; 5 female) underwent EUS-nCLE with surgical resection and subsequent ex vivo imaging (Table 3 ). The mean size of PCLs was 34.8 ± 14.3 mm with the majority of lesions located in the tail (n = 5) when compared to head/uncinate (n = 2) or neck/body region (n = 3). No adverse events occurred during the surgical resection that impacted the quality of the specimen.
Intraductal papillary mucinous neoplasm
Complete "finger-like" papillary projections were seen on in vivo EUS-nCLE and ex vivo pCLE imaging for both patients with IPMNs ( Figure 1 ). The vascular cores (lamina propria) of the papillae were better defined in the ex vivo imaging. There was no difference in in vivo or ex vivo imaging between the different subtypes (gastric vs intestinal) of IPMN lesions. The CLE images and histopathology were similar.
Mucinous cystic neoplasm
EUS-nCLE demonstrated horizon-type epithelial bands of variable thickness without papillary conformation ( Figure 2 and [22] . The Gastroflex-UHD probe has a superior lateral resolution of 1 μm, compared to 3.5 μm for the Cholangioflex probe. The lateral resolutions of the AQ-Flex and Cholangioflex probes are identical [23] .
Histopathology
The resected specimen underwent standard histopathologic processing. The biopsies obtained from pCLE imaged specific sites also underwent standard processing under the supervision of a gastroenterologist pathologist.
Statistical analysis
A dedicated software (Cellvizio Viewer, version 1.6.1; Mauna Kea Technologies, Paris, France) was used to review all in vivo and ex vivo CLE videos and images. A diligent frame-by-frame review of the videos was performed multiple times to document the most illustrative image patterns. The various image patterns observed during CLE examination of the PCLs are described in Table 2 . There was no blinded assessment of the pre-and postoperative CLE images.
Comparison of standard microscopy and CLE imaging
CLE imaging offers an "en-face" view and has resolutions ranging from 1 μm (Gastroflex probe) to 3.5 μm (AQ-Flex probe). In comparison, standard biopsy nCLE, MCNs revealed areas of denuded epithelium as evidenced by lack of visualizing any epithelial bands. Few foci of dark background with bright particles (auto-fluorescent inflammatory cells) were also observed representing areas of chronic inflammation. While the characteristic "ovarian stroma" was detected in histopathology, no corresponding CLE features were observed.
Cystic neuroendocrine tumor
In vivo and ex vivo imaging ( Figure 3 and Table 3) revealed dark clusters or trabeculae of cells separated by bright vascular spaces. Corroborating this finding, corresponding biopsies from the cystic-NETs revealed characteristic well-differentiated NETs, which were confirmed by immunostaining.
Serous cystadenoma
Both EUS-nCLE and ex vivo imaging (Figure 4 and Table 3 ) depict a "fern pattern" of vascularity that is best described as a concentrated parallel or interconnected network of vessels emanating from a larger vessel (similar to a fern leaf). However, the vascular pattern observed in CLE imaging is not represented in histopathology. Characteristic histology of SCAs include multiple cystic spaces lined by cuboidal/flat epithelial cells. The pathology image in Figure 4 (panel C) revealed flattened cystic spaces lined by cuboidal epithelial cells.
Squamous lined cysts (epidermoid and lymphoepithelial cysts)
Two distinct benign cysts, epidermoid cyst of intra pancreatic accessory spleen (IPAS) and lymphoepithelial cyst, were included in this study. The epidermoid cyst of IPAS demonstrated cords of cells suggestive of ectopic splenic tissue. Pathology confirmed these findings revealing a thin squamous epithelium and underlying splenic red pulp ( Figure 5 and Table 3 ). On the other hand, the lymphoepithelial cyst had clusters of bright particles that correlated to keratinous debris seen on pathologic slides ( Figure 6 and Table 3 ). Microscopy demonstrated keratin flakes and the cyst wall was lined by squamous epithelium bordered by abundant lymphoid tissue.
DISCUSSION
This study confirms the reproducibility of in vivo EUSnCLE image patterns in ex vivo pCLE examination of surgically resected PCLs. The histopathology from CLE imaged site-specific biopsies were comparable to CLE patterns. Some variations in histological views can be explained by higher resolution and the plane of image reproduction. While EUS-nCLE produces en-face microscopic imaging of the epithelium of PCLs, tissue histology reveals transverse views. To our knowledge, this is the largest study describing in vivo and ex vivo CLE findings in definitively diagnosed PCLs. We have correlated for the first time, CLE image patterns with surgical histopathology among common PCLs. These promising findings and growing body of literature lend support to further investigation of EUS-nCLE in the management of PCLs. The management of PCLs continues to pose challenges. Suboptimal classification and risk stratification of PCLs can lead to inappropriate surgeries or false reassurances. The current guidelines for management of PCLs are not robust since the diagnostic accuracy of current standard of care (cyst fluid CEA, cytology) is inadequate. There is an increasing need for tools to accurately diagnose PCLs. Over the last 5 years, there is an accumulative body of evidence of applying EUS-nCLE or novel cyst fluid molecular makers in diagnosing PCLs [6] [7] [8] [9] [10] 24] . Imaging data from three major clinical trials have recognized specific nCLE image patterns for diagnosing PCLs [5] [6] [7] [8] . We have recently validated (internally and externally, inter-and intraobserver) nCLE image patterns of common PCLs [9, 10] . We have also published on the technique of in vivo and ex vivo CLE imaging of PCLs, and individual nCLE video reports of IPMNs, MCNs, SCAs, Cystic-NETs, and squamous lined cysts [15] [16] [17] [18] 20] . In this study, we performed ex vivo CLE examination of resected PCLs from subjects enrolled in a prospective study.
For EUS-nCLE aided diagnosis, IPMNs were diagnosed by the presence of finger-like papillae. Although the nCLE image patterns for MCNs were slightly insufficient, they contained a characteristic either single or multiple (layered) band-like epithelium [8, 9] . Thus, the presence of complete papillae or single/multiple band-like epithelium was diagnostic of a mucinous PCL. The diagnosis of IPMNs tends to be easier than that of MCNs since the latter demonstrate relatively flat or horizon-type epithelium which can be patchy with atrophic areas and foci of inflammation [25, 26] . We have observed that some MCNs can demonstrate bright inflammatory cells on a dark background suggestive of chronic inflammation similar to pseudocysts [7, 8] .
A characteristic "superficial vascular network" or "fern pattern" has been observed in SCAs where the specificity approached 100% [5] [6] [7] [8] [9] [10] . Comparable image reproduction in ex vivo CLE imaging and corresponding histopathological image supports evidence from current studies. The nCLE imaging of cystic-NETs and comparable ex vivo image patterns and correlative histopathology confirm published reports [8, 15] . Some rare types of PCLs can be difficult to distinguish by cross sectional imaging and are often evaluated for malignant potential [27] . Thus, awareness of in vivo EUS-nCLE image patterns of rare squamous lined PCLs (lymphoepithelial cyst and epidermoid cyst of IPAS) is useful as it may help avoid unnecessary surgical resection.
The small sample size (n = 10) is not suitable for statistical analysis and the images observed in this study may not fully characterize all patients with the examined cyst types. As with other novel diagnostic modalities, we anticipate further refinement of technical aspects and additional characterization of nCLE imaging patterns in the future. Although our ex vivo nCLE image findings were not externally validated, we have previously performed both internal and external validation of the in vivo nCLE image patterns [9, 10] . Lastly, since surgical resection of pseudocysts rarely performed, we did not perform ex vivo imaging of these lesions within the study period.
In conclusion, the evaluation of PCLs continues to pose a challenge. In uncertain clinical situations, a composite approach including clinical features, imaging characteristics, cyst fluid CEA, cytological examination, and nCLE is necessary. The correlation of histopathology and the reproducibility of in vivo and ex vivo CLE imaging patterns supports the application of EUS-nCLE as an imaging biomarker in the diagnosis of PCLs. Multicenter prospective studies are needed to confirm whether EUS-nCLE alone or in combination with cyst fluid molecular markers can facilitate desirable outcomes in managing pancreatic cystic lesions. 
Research frontiers
The current guidelines for management of PCLs are not robust since the diagnostic accuracy of current standard of care is inadequate. There is an increasing need for novel technology to accurately diagnose PCLs. Over the last 5 years, there is an accumulative body of evidence of applying EUS-nCLE in diagnosing PCLs.
Applications
This study confirms the reproducibility of in vivo EUS-nCLE image patterns in ex vivo pCLE examination of surgically resected PCLs. The histopathology from CLE imaged site-specific biopsies were comparable to CLE patterns. These promising findings lend support to the application of EUS-nCLE in the management of PCLs.
Terminology
Confocal laser endomicroscopy: A novel endoscopic technology that offers real-time microscopic imaging of tissue where the system provides tissue-sequences with high resolution (1-3.5 μm)
facilitating in vivo histopathology.
Peer-review
This new endoscopic technique which is based on confocal microscopy seems very interesting. It allows a pathological diagnosis by acquisition of images that are pathognomonic of the various pancreatic cystic lesions examinated by the authors.
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